Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a cornerstone in type 2 diabetes management, improving glucose-stimulated insulin secretion, slowing gastric emptying and reducing blood glucose levels [1, 2]. Here, GLP1R is linked to type 2 diabetes mellitus.